Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins
Authors:
- Geesje M Dallinga-ThieGDGeesje M Dallinga-Thie
- Robin Pf DullaartRDRobin Pf Dullaart
- Arie van TolATArie van Tol
- 1 June 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 18 (3) , 251-257
Abstract
Type 2 diabetes frequently coincides with dyslipidemia, characterized by elevated plasma triglycerides, low high-density lipoprotein cholesterol levels and the presence of small dense low-density lipoprotein particles. Plasma lipid transfer proteins play an essential role in lipoprotein metabolism. It is thus vital to understand their pathophysiology and determine which factors influence their functioning in type 2 diabetes. Cholesteryl ester transfer protein-mediated transfer is increased in diabetic patients and contributes to low plasma high-density lipoprotein cholesterol levels. Apolipoproteins A-I, A-II and E are components of the donor lipoprotein particles that participate in the transfer of cholesteryl esters from high-density lipoprotein to apolipoprotein B-containing lipoproteins. Current evidence for functional roles of apolipoproteins C-I, F and A-IV as modulators of cholesteryl ester transfer is discussed. Phospholipid transfer protein activity is increased in diabetic patients and may contribute to hepatic very low-density lipoprotein synthesis and secretion and vitamin E transfer. Apolipoprotein E could stimulate the phospholipid transfer protein-mediated transfer of surface fragments of triglyceride-rich lipoproteins to high-density lipoprotein, and promote high-density lipoprotein remodelling. Both phospholipid and cholesteryl ester transfer proteins are important in very low and high-density lipoprotein metabolism and display concerted actions in patients with type 2 diabetes.Keywords
This publication has 86 references indexed in Scilit:
- Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptorBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- Apolipoprotein E activates the low-activity form of human phospholipid transfer proteinBiochemical and Biophysical Research Communications, 2005
- Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sampleJournal of Lipid Research, 2004
- Plasma turnover of HDL apoC-I, apoC-III, and apoE in humansJournal of Lipid Research, 2003
- PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasmaJournal of Lipid Research, 2003
- Isolation and Partial Characterization of the Inactive and Active Forms of Human Plasma Phospholipid Transfer Protein (PLTP)Journal of Biological Chemistry, 2002
- Phospholipid transfer proteinCurrent Opinion in Lipidology, 2002
- Mass Concentration of Plasma Phospholipid Transfer Protein in Normolipidemic, Type IIa Hyperlipidemic, Type IIb Hyperlipidemic, and Non–Insulin-Dependent Diabetic Subjects as Measured by a Specific ELISAArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Phospholipid transfer protein mediated conversion of high density lipoproteins generates preβ1-HDLBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Activation of human plasma cholestryl ester transfer protein by human apolipoprotein A-IVBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996